The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

Radiotherapy (RT) is a common treatment for localised prostate cancer, but can cause important side effects. The therapeutic efficacy of RT can be enhanced by pharmacological compounds that target specific pathways involved in cell survival. This would elicit a similar therapeutic response using low...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz, R, Nguewa, P A, Diaz-Gonzalez, J A, Hamel, E, Gonzalez-Moreno, O, Catena, R, Serrano, D, Redrado, M, Sherris, D, Calvo, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661786/
https://www.ncbi.nlm.nih.gov/pubmed/19240717
http://dx.doi.org/10.1038/sj.bjc.6604938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661786/
https://www.ncbi.nlm.nih.gov/pubmed/19240717
http://dx.doi.org/10.1038/sj.bjc.6604938

Ejemplares similares